(Q46280407)

English

Dose-related suppression of serum luteinizing hormone in women by a potent new gonadotropin-releasing hormone antagonist (Ganirelix) administered by intranasal spray

scientific article published in March 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

Dose-related suppression of serum luteinizing hormone in women by a potent new gonadotropin-releasing hormone antagonist (Ganirelix) administered by intranasal spray (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

author name string

V Y Fujimoto

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

S E Monroe

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

L R Nelson

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

D Downey

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

R B Jaffe

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

language of work or name

0 references

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

67

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

469-473

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Gonadotropin releasing hormone activation is mediated by dimerization of occupied receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Luteinizing hormone release from dissociated pituitary cells by dimerization of occupied LHRH receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

The dynamics of gonadotropin inhibition in women induced by an antagonistic analog of gonadotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Sustained inhibitory actions of a potent antagonist of gonadotropin-releasing hormone in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Reproductive/endocrine and anaphylactoid properties of an LHRH-antagonist, ORF 18260 [Ac-DNAL1(2), 4FDPhe2,D-Trp3,D-Arg6]-GnRH.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix).

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Potent gonadotropin releasing hormone antagonists with low histamine-releasing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Radioimmunoassay of ganirelix in plasma or serum

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Inhibition of follicular development by a potent antagonistic analog of gonadotropin-releasing hormone (detirelix).

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980071-4

7 January 2021

Identifiers

10.1016/S0015-0282(97)80071-4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9091332

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46280407&oldid=2103028121"